PortfoliosLab logoPortfoliosLab logo
ABBV vs. PCN
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ABBV vs. PCN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and PIMCO Corporate & Income Strategy Fund (PCN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABBV achieves a 1.30% return, which is significantly higher than PCN's -3.20% return. Over the past 10 years, ABBV has outperformed PCN with an annualized return of 19.10%, while PCN has yielded a comparatively lower 7.31% annualized return.


ABBV

1D
1.32%
1M
8.24%
YTD
1.30%
6M
3.65%
1Y
23.06%
3Y*
22.39%
5Y*
18.94%
10Y*
19.10%

PCN

1D
0.52%
1M
0.45%
YTD
-3.20%
6M
-0.94%
1Y
4.06%
3Y*
8.59%
5Y*
0.74%
10Y*
7.31%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ABBV vs. PCN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ABBV
AbbVie Inc.
1.30%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%
PCN
PIMCO Corporate & Income Strategy Fund
-3.20%5.55%19.52%16.22%-22.88%6.93%-2.19%39.10%-5.94%26.20%

Correlation

The correlation between ABBV and PCN is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.14

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ABBV vs. PCN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV
ABBV Risk / Return Rank: 6868
Overall Rank
ABBV Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6666
Sortino Ratio Rank
ABBV Omega Ratio Rank: 6565
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6868
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6868
Martin Ratio Rank

PCN
PCN Risk / Return Rank: 77
Overall Rank
PCN Sharpe Ratio Rank: 77
Sharpe Ratio Rank
PCN Sortino Ratio Rank: 77
Sortino Ratio Rank
PCN Omega Ratio Rank: 77
Omega Ratio Rank
PCN Calmar Ratio Rank: 66
Calmar Ratio Rank
PCN Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABBV vs. PCN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and PIMCO Corporate & Income Strategy Fund (PCN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ABBVPCNDifference
Sharpe ratioReturn per unit of total volatility

+0.61

Sortino ratioReturn per unit of downside risk

+0.91

Omega ratioGain probability vs. loss probability

1.18

1.07

+0.10

Calmar ratioReturn relative to maximum drawdown

1.29

0.29

+1.00

Martin ratioReturn relative to average drawdown

2.88

0.81

+2.07

ABBV vs. PCN - Sharpe Ratio Comparison

The current ABBV Sharpe Ratio is 0.92, which is higher than the PCN Sharpe Ratio of 0.31. The chart below compares the historical Sharpe Ratios of ABBV and PCN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ABBV vs. PCN - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum PCN drawdown of -61.12%. Use the drawdown chart below to compare losses from any high point for ABBV and PCN.


Loading charts...

Drawdown Indicators


ABBVPCNDifference

Max Drawdown

Largest peak-to-trough decline

-45.09%

-61.12%

+16.03%

Max Drawdown (1Y)

Largest decline over 1 year

-17.32%

-10.40%

-6.92%

Max Drawdown (3Y)

Largest decline over 3 years

-20.74%

-22.53%

+1.79%

Max Drawdown (5Y)

Largest decline over 5 years

-21.92%

-33.39%

+11.47%

Max Drawdown (10Y)

Largest decline over 10 years

-45.09%

-50.27%

+5.18%

Current Drawdown

Current decline from peak

-4.60%

-5.72%

+1.12%

Average Drawdown

Average peak-to-trough decline

-10.71%

-7.20%

-3.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.75%

3.70%

+4.05%

Volatility

ABBV vs. PCN - Volatility Comparison

AbbVie Inc. (ABBV) has a higher volatility of 6.10% compared to PIMCO Corporate & Income Strategy Fund (PCN) at 2.95%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than PCN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABBVPCNDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.10%

2.95%

+3.15%

Volatility (6M)

Calculated over the trailing 6-month period

17.85%

7.19%

+10.66%

Volatility (1Y)

Calculated over the trailing 1-year period

24.31%

9.77%

+14.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.89%

16.19%

+6.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.73%

21.94%

+3.79%

Dividends

ABBV vs. PCN - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 2.96%, less than PCN's 11.55% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.96%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
PCN
PIMCO Corporate & Income Strategy Fund
11.55%10.58%10.06%10.88%12.66%7.89%7.83%7.37%9.60%7.85%11.98%10.22%

Frequently Asked Questions


ABBV and PCN have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (6.10%) compared to PCN (2.95%). In terms of maximum drawdown, ABBV dropped -45.09% vs PCN's -61.12%.

ABBV currently has the higher Sharpe Ratio (0.92 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABBV and PCN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer